Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Dithiazole-based MMP inhibitors newly discovered at Shiseido

April 23, 2003

Clinical testing of Tbeta4 begins at RegeneRx

April 10, 2003

Jerini decapeptide designated orphan drug for angioedema

April 10, 2003

Infliximab effective and well tolerated in plaque psoriasis

April 10, 2003

New data on alitretinoin and bexarotene in dermatological disorders

April 10, 2003

Elidel approved in Switzerland

April 9, 2003

Prous Science announces publication of state-of-the-art review: acne vulgaris

April 8, 2003

Metvix PDT approved in Australia

April 7, 2003

Phase III program under way for Seboride

April 4, 2003

Galen enters agreements for psoriasis treatments

April 4, 2003

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...